Vor Biopharma Inc (NASDAQ:VOR) shares, rose in value on Thursday, April 16, without any change to the previous day’s close as strong demand from buyers drove the stock to $0.65.
Actively observing the price movement in the last trading, the stock closed the session at $0.65, falling within a range of $0.63 and $0.6994. The value of beta (5-year monthly) was -0.212. Referring to stock’s 52-week performance, its high was $1.95, and the low was $0.49. On the whole, VOR has fluctuated by -22.99% over the past month.
With the market capitalization of Vor Biopharma Inc currently standing at about $81.15 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-19.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VOR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of VOR currently trading nearly -5.42% and -31.60% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.83, while the 7-day volatility ratio is showing 11.32% which for the 30-day chart, stands at 10.43%. Furthermore, Vor Biopharma Inc (VOR)’s beta value is -0.18, and its average true range (ATR) is 0.08.
A comparison of Vor Biopharma Inc (VOR) with its peers suggests the former has fared considerably weaker in the market. VOR showed an intraday change of 0.00% in last session, and over the past year, it shrunk by -61.99%%.
Data on historical trading for Vor Biopharma Inc (NASDAQ:VOR) indicates that the trading volumes over the past 10 days have averaged 0.22 and over the past 3 months, they’ve averaged 353.37K. According to company’s latest data on outstanding shares, there are 124.78 million shares outstanding.
Nearly 38.50% of Vor Biopharma Inc’s shares belong to company insiders and institutional investors own 43.00% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.33 million shares as on 2025-03-31, resulting in a short ratio of 4.61. According to the data, the short interest in Vor Biopharma Inc (VOR) stood at 142.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.45 million. The stock has fallen by -41.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VOR stock heading into the next quarter.
